In this episode of our podcast, Conversations with B’nai B’rith, Dr. Talia Cohen Solal, co-founder and CEO of Israeli health-tech firm NeuroKaire (formerly known as Genetika+), speaks with B’nai B’rith CEO Dan Mariaschin about how her company combines cutting-edge stem cell technology with artificial intelligence (AI) software to better match drugs to patients. She also explores NeuroKaire’s collaboration on a promising new Alzheimer’s treatment.

WATCH the interview on YouTube and Facebook.